par Lisa Chamoff
, Contributing Reporter | June 17, 2019
From the June 2019 issue of HealthCare Business News magazine
Another feature of the 800 series is SwiftScan Planar and SwiftScan SPECT technologies, with increased sensitivity that Hermony said allows for 25 percent faster imaging.
The 870 CZT also comes with new feature that allows the scanner to continuously acquire data in SPECT mode, improving sensitivity by 40 percent, Hermony said.
On the PET side, GE Healthcare has also developed a technology to eliminate blurring created by respiration. Called MotionFree, the technology will negate the use of specific devices to correct motion by using an advanced algorithm, said Sergio Calvo, general manager for PET at GE Healthcare.
Eliminating motion is critical for detecting smaller lesions and metastases, Calvio said.
“It makes a huge difference to enable motion elimination in critical areas of the body,” Calvo said.
MotionFree has received FDA clearance and is now available for GE Healthcare’s Discovery MI and MI DR series of PET scanners.
Philips Vereos PET/CT Ambient Experience
Philips is continuing to build on the foundation of its Vereos, the digital PET/CT system it began shipping at the end of 2017.
In February, the company announced the launch of IntelliSpace Portal 11, the latest release of its comprehensive, advanced visualization and quantification software.
Mark Olszewski, global marketing leader for CT and advanced molecular imaging at Philips, said the company plans to share more results from its work with clinical partners in the oncology, neurology, and cardiac spaces; next steps in advanced image reconstruction; and pairing the Vereos with the company’s PerformanceBridge data analytics platform at the SNMMI annual meeting this month in Anaheim, California.
“We’re using adaptive intelligence to help our customers increase the speed and precision of their diagnoses,” Olszewski said.
RefleXion biology-guided radiotherapy (BgRT)
RefleXion Medical bridges PET imaging and stereotactic radiotherapy with its biology-guided radiotherapy (BgRT), which uses emissions from PET signals to guide therapy in real time.